News

The grant is subject to payment of fees and completion of final amendments and formalities. When issued, the patent claims ...
Protagenic Therapeutics, Inc. (Nasdaq: PTIX) (the 'Company”) today announces that on July 18, 2025, the Japanese Patent ...
Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced that Maroun S.
OncoZenge AB (publ) ("OncoZenge" or "the Company") today announced a comprehensive market and strategy update after successfully securing full funding for its BupiZenge Phase 3 clinical trial aimed at ...
Arsenal star Jurrien Timber has joined a growing group of athletes investing in Hytro, the UK-based blood flow restriction ...
Automotive engineer Christian von Koenigsegg received a patent for a futuristic closed-wing design that could reduce airplane drag.
As Keytruda generic competition looms larger on the horizon, the company is hoping to reinvest the savings into pipeline growth drivers.
Patent thickets hinder biosimilar access, driving up costs and delaying affordable treatments. Discover legislative solutions to enhance competition and patient care.
Tal Benschar discusses how the Eleventh Circuit ruled that a foreign intellectual property holding company can be subject to ...
Galderma is a pure-play dermatology company, with a leadership position in the self-care segment of the market, with more than 90% of total sales paid by consumers out of pocket. Its long-term revenue ...
Pill penalty disincentivizes R&D At a superficial level this results in somewhat lower drug prices, but it disincentivizes ...
In the lawsuit, Sony calls Tencent's Light of Motiram a "slavish clone" of the Horizon series that copies its entire ...